Skip to content

Which Type of Transcutaneous Electrical Nerve Stimulation is More Effective in Myofascial Pain Syndrome?

Which Type of Transcutaneous Electrical Nerve Stimulation is More Effective in Myofascial Pain Syndrome? A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04645095
Enrollment
101
Registered
2020-11-27
Start date
2017-05-05
Completion date
2020-03-01
Last updated
2020-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain Syndromes

Keywords

Myofascial Pain Syndromes, Transcutaneous Electrical Nerve Stimulation

Brief summary

The aim of this project is to compare the effects of conventional, burst and modulated TENS primarily on pain level, number of trigger points, pressure pain threshold, neck joint range of motion and disability in MAS treatment.

Detailed description

Myofascial pain syndrome (MAS) is a regional pain syndrome characterized by trigger points detected by one or several muscle groups and reflected pain manifestation caused by palpation of these points. Transcutaneous electrical nerve stimulation (TENS) is a physical therapy modality that provides an analgesic effect by delivering a controlled low voltage electrical current to the nervous system through electrodes placed on the skin. Knowledge on how modulation parameters such as frequency, wave width and form alter TENS activity are limited.

Interventions

DEVICETranscutaneous electrical nerve stimulation

All groups were administered hotpack for 20 minutes, different types of TENS therapy for 20 minutes, 5 days a week, total of 15 sessions.

DEVICEHot pack

All groups were administered hotpack for 20 minutes, different types of TENS therapy for 20 minutes, 5 days a week, total of 15 sessions.

Sponsors

Ankara University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Having a diagnosis of myofascial pain syndrome according to the criteria defined by Travell and Simons

Exclusion criteria

* The onset of symptoms is less than 3 months * Severe cervical disc hernia, radiculopathy or myelopathy * Stage 3-4 cervical degeneration * Tumoral, infectious, psychiatric, neurological, uncontrolled systemic disease * Cardiac pacemaker * Diagnosed with fibromyalgia syndrome * Kyphoscoliosis * Acute trauma history * Having had previous brain or shoulder surgery * Injections for MAS and / or physiotherapy programs in the last 3 months * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Pain intensityMeasurements will be made before treatment, at the 1st week after treatment and at the 1st month after treatment.using Visual Analog Scale score; (0-10); 0 indicates no pain and 10 indicates worst imaginable pain
Number of trigger points in the upper back regionMeasurements will be made before treatment, at the 1st week after treatment and at the 1st month after treatment.using number
Pressure painMeasurements will be made before treatment, at the 1st week after treatment and at the 1st month after treatment.using algometer (kg/cm2)
Neck joint range of motionMeasurements will be made before treatment, at the 1st week after treatment and at the 1st month after treatment.using double inclinometer
DisabilityMeasurements will be made before treatment, at the 1st week after treatment and at the 1st month after treatment.using Modified Neck Disability Index

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026